Victor Puac-Polanco
Overview
Explore the profile of Victor Puac-Polanco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez D, Staley B, Andrea S, DeVilbiss E, Fink D, Pena C, et al.
Am J Epidemiol
. 2024 Jun;
PMID: 38863127
No abstract available.
2.
Czepiel D, McCormack C, da Silva A, Seblova D, Moro M, Restrepo-Henao A, et al.
Glob Ment Health (Camb)
. 2024 Apr;
11:e34.
PMID: 38572248
Healthcare workers (HCWs) were at increased risk for mental health problems during the COVID-19 pandemic, with prior data suggesting women may be particularly vulnerable. Our global mental health study aimed...
3.
Puac-Polanco V, Ziobrowski H, Ross E, Liu H, Turner B, Cui R, et al.
Psychol Med
. 2023 Aug;
53(11):5001-5011.
PMID: 37650342
Background: Only a limited number of patients with major depressive disorder (MDD) respond to a first course of antidepressant medication (ADM). We investigated the feasibility of creating a baseline model...
4.
Cohen G, Bor J, Keyes K, Demmer R, Stellman S, Puac-Polanco V, et al.
Prev Med
. 2023 Aug;
175:107653.
PMID: 37532031
Tobacco taxes have reduced smoking and coronary heart disease (CHD) mortality, yet few studies have examined heterogeneity of these associations by race and gender. We constructed a yearly panel (2005-2016)...
5.
Kazdin A, Wu C, Hwang I, Puac-Polanco V, Sampson N, Al-Hamzawi A, et al.
Psychol Med
. 2023 Apr;
53(4):1583-1591.
PMID: 37010212
Background: The most common treatment for major depressive disorder (MDD) is antidepressant medication (ADM). Results are reported on frequency of ADM use, reasons for use, and perceived effectiveness of use...
6.
Bossarte R, Ross E, Liu H, Turner B, Bryant C, Zainal N, et al.
J Affect Disord
. 2023 Jan;
326:111-119.
PMID: 36709831
Background: Although research shows that more depressed patients respond to combined antidepressants (ADM) and psychotherapy than either alone, many patients do not respond even to combined treatment. A reliable prediction...
7.
Paniagua-Avila A, Ramirez D, Barrera-Perez A, Calgua E, Castro C, Peralta-Garcia A, et al.
Rev Panam Salud Publica
. 2022 Aug;
46:e79.
PMID: 35990526
Objectives: To assess the baseline prevalence of mental health conditions and associated exposures in a cohort of health care workers (HCWs) in Guatemala. Methods: We analyzed baseline information from the...
8.
Paniagua-Avila A, Ramirez D, Barrera-Perez A, Calgua E, Castro C, Peralta-Garcia A, et al.
Am J Public Health
. 2022 Aug;
112(S6):S602-S614.
PMID: 35977333
To assess the baseline prevalence of mental health conditions and associated exposures in a cohort of health care workers (HCWs) in Guatemala. We analyzed baseline information from the 2020 Web-based...
9.
Kessler R, Ruhm C, Puac-Polanco V, Hwang I, Lee S, Petukhova M, et al.
JAMA Netw Open
. 2022 Jun;
5(6):e2217223.
PMID: 35704316
Importance: Claims of dramatic increases in clinically significant anxiety and depression early in the COVID-19 pandemic came from online surveys with extremely low or unreported response rates. Objective: To examine...
10.
Kessler R, Kazdin A, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Altwaijri Y, et al.
World Psychiatry
. 2022 May;
21(2):272-286.
PMID: 35524618
Patient-reported helpfulness of treatment is an important indicator of quality in patient-centered care. We examined its pathways and predictors among respondents to household surveys who reported ever receiving treatment for...